keyword
MENU ▼
Read by QxMD icon Read
search

Breast-Q reduction

keyword
https://www.readbyqxmd.com/read/28614589/lactoferrin-protects-against-intestinal-inflammation-and-bacteria-induced-barrier-dysfunction-in-vitro
#1
Nina A Hering, Julia Luettig, Susanne M Krug, Stephanie Wiegand, Gabriele Gross, Eric A van Tol, Jörg D Schulzke, Rita Rosenthal
The iron-binding glycoprotein lactoferrin (LF) is naturally present in human breast milk. Several studies suggest that LF contributes to infant health and development owing to a variety of protective effects, including antimicrobial and anti-inflammatory features. Therefore, we aimed to elucidate its protective properties on intestinal epithelial barrier dysfunction induced by infection or inflammation using the human epithelial cell culture models HT-29/B6 and T84. During barrier perturbation induced by the proinflammatory cytokine tumor necrosis factor α (TNF-α), bovine LF restored tight junction (TJ) morphometry and inhibited TNF-α-induced epithelial apoptosis...
June 14, 2017: Annals of the New York Academy of Sciences
https://www.readbyqxmd.com/read/28578506/first-international-consensus-conference-on-standardization-of-oncoplastic-breast-conserving-surgery
#2
Walter P Weber, Savas D Soysal, Mahmoud El-Tamer, Virgilio Sacchini, Michael Knauer, Christoph Tausch, Nik Hauser, Andreas Günthert, Yves Harder, Elisabeth A Kappos, Fabienne Schwab, Florian Fitzal, Peter Dubsky, Vesna Bjelic-Radisic, Roland Reitsamer, Rupert Koller, Jörg Heil, Markus Hahn, Jens-Uwe Blohmer, Jürgen Hoffmann, Christine Solbach, Christoph Heitmann, Bernd Gerber, Martin Haug, Christian Kurzeder
PURPOSE: To obtain consensus recommendations for the standardization of oncoplastic breast conserving surgery (OPS) from an international panel of experts in breast surgery including delegates from the German, Austrian and Swiss societies of senology. METHODS: A total of 52 questions were addressed by electronic voting. The panel's recommendations were put into context with current evidence and the report was circled in an iterative open email process until consensus was obtained...
June 3, 2017: Breast Cancer Research and Treatment
https://www.readbyqxmd.com/read/28570465/shared-medical-appointments-for-adolescent-breast-reduction
#3
Tara L Braun, Matthew G Kaufman, Cristina Hernandez, Laura A Monson
Adolescents with macromastia face serious physical, emotional, and social burdens because of their large breast size. Studies have shown that reduction mammoplasty results in improvement in physical symptoms and quality of life for these patients. Shared medical appointments (SMAs), defined as individual patient-physician encounters that occur in a group setting, have been successfully applied to clinics for adult patients seeking breast reduction for this condition. We decided to apply the SMA model to our clinic for preoperative evaluation of adolescent patients with macromastia...
May 31, 2017: Annals of Plastic Surgery
https://www.readbyqxmd.com/read/28554725/substrate-inhibition-of-17beta-hsd1-in-living-cells-and-regulation-of-17beta-hsd7-by-17beta-hsd1-knockdown
#4
Hui Han, Jean-François Thériault, Guang Chen, Sheng-Xiang Lin
This study addresses first the role of human 17beta-hydroxysteroid dehydrogenase type 1 (17β-HSD1) in breast cancer (BC). The enzyme has a high estrone-activating activity that is subject to strong substrate inhibition as shown by enzyme kinetics at the molecular level. We used BC cells to verify this phenomenon in living cells: estrone concentration increase did reduce the reaction with 0.025 to 4μM substrate. Moreover, 5α-dihydrotestosterone (DHT) demonstrated some inhibition of estrogen activation at both the molecular and cellular level...
May 26, 2017: Journal of Steroid Biochemistry and Molecular Biology
https://www.readbyqxmd.com/read/28467786/a-phase-i-study-of-the-src-kinase-inhibitor-dasatinib-with-trastuzumab-and-paclitaxel-as-first-line-therapy-for-patients-with-her2-overexpressing-advanced-breast-cancer-geicam-2010-04-study
#5
Alberto Ocana, Marta Gil-Martin, Miguel Martín, Federico Rojo, Silvia Antolín, Ángel Guerrero, José Manuel Trigo, Montse Muñoz, Atanasio Pandiella, Núria Gonzalo Diego, Susana Bezares, Rosalía Caballero, Eva Carrasco, Ander Urruticoechea
The anti-HER2 antibody trastuzumab have shown clinical activity in combination with chemotherapy in different breast cancer settings. However, most of patients treated with this antibody progress after a period of treatment. Activation of the kinase SRC has been linked with resistance to trastuzumab in several preclinical studies. We designed a phase I clinical study to explore the activity of weekly trastuzumab (2 mg/kg) plus paclitaxel (80 mg/m2) in combination with the anti-SRC kinase inhibitor Dasatinib in the first line treatment of HER2 metastatic breast cancer...
April 14, 2017: Oncotarget
https://www.readbyqxmd.com/read/28464217/oncoplastic-breast-surgery-achieving-oncological-and-aesthetic-outcomes
#6
Maaike W van Paridon, Parisa Kamali, Marek A Paul, Winona Wu, Ahmed M S Ibrahim, Kari J Kansal, Mary Jane Houlihan, Donald J Morris, Bernard T Lee, Samuel J Lin, Ranjna Sharma
BACKGROUND AND OBJECTIVES: Oncoplastic reconstruction allows more patients to become candidates for breast-conserving surgery (BCS). Oncologic resection of a breast lesion is combined with plastic surgical techniques to improve aesthetic results. Choosing the best oncoplastic method is essential to optimize outcomes, improve cosmesis, and minimize postoperative complications. The aim of this study is to present a treatment algorithm incorporating oncoplastic techniques based on diagnosis, tumor size, tumor location, and breast size and shape...
May 2, 2017: Journal of Surgical Oncology
https://www.readbyqxmd.com/read/28452833/neoadjuvant-therapy-combined-with-oncoplastic-reduction-for-high-stage-breast-cancer-patients
#7
Justine S Broecker, Alexandra M Hart, Toncred M Styblo, Albert Losken
OBJECTIVE: Oncoplastic surgery has been shown to be a good alternative to breast conservation surgery (BCS) alone for patients with breast cancer. Its role in patients with advanced disease is unclear. In this study, we evaluate the safety of oncoplastic BCS (OBCS) in patients who received neoadjuvant therapy (NT) for high stage breast cancer. METHODS: The oncologic outcomes of consecutive patients classified as high stage (>T2 or at least N1) who received NT followed by BCS at EUH by a single breast surgeon (T...
June 2017: Annals of Plastic Surgery
https://www.readbyqxmd.com/read/28398847/traceback-a-proposed-framework-to-increase-identification-and-genetic-counseling-of-brca1-and-brca2-mutation-carriers-through-family-based-outreach
#8
Goli Samimi, Marcus Q Bernardini, Lawrence C Brody, Charlisse F Caga-Anan, Ian G Campbell, Georgia Chenevix-Trench, Fergus J Couch, Michael Dean, Joanne A de Hullu, Susan M Domchek, Ronny Drapkin, Heather Spencer Feigelson, Michael Friedlander, Mia M Gaudet, Marline G Harmsen, Karen Hurley, Paul A James, Janice S Kwon, Felicitas Lacbawan, Stephanie Lheureux, Phuong L Mai, Leah E Mechanic, Lori M Minasian, Evan R Myers, Mark E Robson, Susan J Ramus, Lisa F Rezende, Patricia A Shaw, Thomas P Slavin, Elizabeth M Swisher, Masataka Takenaka, David D Bowtell, Mark E Sherman
In May 2016, the Division of Cancer Prevention and the Division of Cancer Control and Population Sciences, National Cancer Institute, convened a workshop to discuss a conceptual framework for identifying and genetically testing previously diagnosed but unreferred patients with ovarian cancer and other unrecognized BRCA1 or BRCA2 mutation carriers to improve the detection of families at risk for breast or ovarian cancer. The concept, designated Traceback, was prompted by the recognition that although BRCA1 and BRCA2 mutations are frequent in women with ovarian cancer, many such women have not been tested, especially if their diagnosis predated changes in testing guidelines...
April 11, 2017: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/28350653/understanding-the-health-burden-of-macromastia-normative-data-for-the-breast-q-reduction-module
#9
Lily R Mundy, Karen Homa, Anne F Klassen, Andrea L Pusic, Carolyn L Kerrigan
BACKGROUND: The BREAST-Q Reduction module evaluates outcomes in reduction mammaplasty. However, there are currently no published normative scores, limiting the interpretation of BREAST-Q data. METHODS: The BREAST-Q Reduction module was administered via the Army of Women, an online community of women (with and without breast cancer) engaged in breast-cancer related research. Normative data were generated from women aged 18 years and older, without a history of breast cancer or breast surgery...
April 2017: Plastic and Reconstructive Surgery
https://www.readbyqxmd.com/read/28350649/oncoplastic-breast-reduction-technique-and-outcomes-an-evolution-over-20-years
#10
Albert Losken, Alexandra M Hart, Justine S Broecker, Toncred M Styblo, Grant W Carlson
BACKGROUND: Reduction mammaplasty at the time of lumpectomy is a good option in women with breast cancer and macromastia. We critically evaluated refinements and outcomes of this technique. METHODS: A prospectively maintained database was reviewed of all women with breast cancer who received lumpectomy and reduction mammaplasty at our institution from 1994 to 2015. Patients' demographics were reviewed. Preoperative and postoperative patient satisfaction (BREAST-Q) was determined...
April 2017: Plastic and Reconstructive Surgery
https://www.readbyqxmd.com/read/28297325/an-evaluation-of-organ-dose-modulation-on-a-ge-optima-ct660-computed-tomography-scanner
#11
Matthew T Dixon, Robert J Loader, Gregory C Stevens, Nick P Rowles
Organ Dose Modulation or ODM (GE Healthcare, Milwaukee, WI) was evaluated to characterize changes in CTDIvol, image noise, effective dose, and organ dose saving to patients. Three separate investigations were completed: a tube current modulation phantom was scanned with and without ODM, a CTDIvol phantom was scanned with ODM, and Monte Carlo simulations were performed. ODM was found to reduce the CTDIvol by approximately 20% whilst increasing the noise by approximately 14%. This was reflected in the dose distribution, where the anterior peripheral dose was reduced by approximately 40% whilst the identical posterior dose remained largely unaffected...
May 2016: Journal of Applied Clinical Medical Physics
https://www.readbyqxmd.com/read/28277070/analysis-of-satisfaction-after-breast-reduction-comparing-vertical-scar-versus-inverted-t-shaped-technique-using-the-breast-q-questionnaire-is-patient-satisfaction-influenced-by-the-amount-of-tissue-removed
#12
Aránzazu Menéndez-Cardo, Francisco Guillen-Grima, Bernardo Hontanilla
BACKGROUND: Breast reduction is a procedure with a high rate of patient satisfaction. Many techniques can be used for this type of surgery; patient satisfaction can vary from one technique to another. The main aim of this study was to use Breast-Q for initial evaluation of patient satisfaction after breast reduction by either vertical or inverted-T technique and then determine if the quantity of breast tissue removed had any influence on patient satisfaction. METHODS: Eighty-four out of 288 patients operated on between 2000 and 2013 anonymously completed the post-operative version of Breast-Q Reduction/Mastopexy...
February 24, 2017: Journal of Plastic Surgery and Hand Surgery
https://www.readbyqxmd.com/read/28062965/patient-satisfaction-and-clinical-outcomes-following-414-breast-reductions-application-of-breast-q
#13
A Cogliandro, M Barone, G Cassotta, S Tenna, B Cagli, P Persichetti
BACKGROUND: The aim of this study was to measure breast satisfaction and quality of life using the BREAST-Q Reduction Module in a large sample of postoperative patients having breast reduction using the inverted T technique. METHODS: With due approval from the ethics committee of our university, 414 patients who were seen in consultation for breast reduction surgery between 2005 and 2015 performed by the same team were asked to fill out BREAST-Q surveys. The patient factors collected for all those undergoing breast reduction included age, body mass index, incision pattern, areola complex pedicle used, amount of tissue resected, concurrent procedures, and complications...
January 7, 2017: Aesthetic Plastic Surgery
https://www.readbyqxmd.com/read/28046484/we-ab-209-05-development-of-an-ultra-fast-high-quality-whole-breast-radiotherapy-treatment-planning-system
#14
Y Sheng, T Li, S Yoo, F Yin, R Blitzblau, J Horton, M Palta, C Hahn, Y Ge, Q Wu
PURPOSE: To enable near-real-time (<20sec) and interactive planning without compromising quality for whole breast RT treatment planning using tangential fields. METHODS: Whole breast RT plans from 20 patients treated with single energy (SE, 6MV, 10 patients) or mixed energy (ME, 6/15MV, 10 patients) were randomly selected for model training. Additional 20 cases were used as validation cohort. The planning process for a new case consists of three fully automated steps:1...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/27453120/-discussion-of-breast-cancer-screening-model-in-china
#15
W Q Li, R Li, P F Liu, Y B Huang
Cancer screening has been considered as double-edged sword with both advantages and disadvantages. For decades, there have been strong interests in screening strategies for the early detection of cancers to reduce the mortality, especially breast X-ray(mammography)screening. However, several evidences also suggested that the benefit of reduction of breast-cancer mortality with mammography might become a problem due to the repeat mammography, subsequent biopsies, and overdiagnosis. And different screening strategies with different models, different intervals, and different target populations also incurred debates...
July 2016: Zhonghua Liu Xing Bing Xue za Zhi, Zhonghua Liuxingbingxue Zazhi
https://www.readbyqxmd.com/read/27393183/patient-satisfaction-with-nipple-sparing-mastectomy-a-prospective-study-of-patient-reported-outcomes-using-the-breast-q
#16
Michael A Howard, Mark Sisco, Katharine Yao, David J Winchester, Ermilo Barrera, Jeremy Warner, Jennifer Jaffe, Peter Hulick, Kristine Kuchta, Andrea L Pusic, Stephen F Sener
BACKGROUND AND OBJECTIVES: The authors sought to study patient-reported outcomes following nipple-sparing mastectomy (NSM). METHODS: From 2008 to 2011, the BREAST-Q was administered to women undergoing NSM surgery for cancer treatment or risk-reduction prior to surgery and at 2 years after completion of reconstruction. The change in score over time and the impact of surgical indication, complication occurrence, and laterality on scores were analyzed. RESULTS: The BREAST-Q was prospectively administered to 39 women undergoing NSM for cancer treatment (n = 17) or risk-reduction (RR) (n = 22)...
September 2016: Journal of Surgical Oncology
https://www.readbyqxmd.com/read/27312036/clinical-outcome-and-patient-satisfaction-with-the-use-of-bovine-derived-acellular-dermal-matrix-surgimend%C3%A2-in-implant-based-immediate-reconstruction-following-skin-sparing-mastectomy-a-prospective-observational-study-in-a-single-centre
#17
Hannah Headon, Abdul Kasem, Aisling Manson, Christina Choy, Amtul R Carmichael, Kefah Mokbel
INTRODUCTION: The advent of acellular dermal matrix devices (ADMs) has enhanced both the scope of implant-based immediate breast reconstruction (IBR) following skin sparing mastectomy (SSM) for the treatment or risk reduction of breast cancer. Currently, there are a wide range of options available for the use of ADMs. METHODS: This is a prospective observational single institution study of 118 consecutive patients undergoing a total of 164 SSM and IBR procedures either for treatment for breast cancer or for risk reduction, between 2012 and 2014...
June 2016: Surgical Oncology
https://www.readbyqxmd.com/read/27179527/development-of-a-japanese-version-of-the-breast-q-and-the-traditional-psychometric-test-of-the-mastectomy-module-for-the-assessment-of-hrqol-and-patient-satisfaction-following-breast-surgery
#18
Miho Saiga, Naruto Taira, Yoshihiro Kimata, Satoko Watanabe, Yuko Mukai, Kojiro Shimozuma, Taeko Mizoo, Tomohiro Nogami, Takayuki Iwamoto, Takayuki Motoki, Tadahiko Shien, Junji Matsuoka, Hiroyoshi Doihara
BACKGROUND: An understanding of health-related quality of life (HRQOL) is of utmost importance in both oncological and esthetic breast surgery. The BREAST-Q is a patient-reported outcome (PRO) measure that investigates HRQOL and patient satisfaction before and after breast surgery. The aim of this study was to develop a Japanese version of the BREAST-Q including the mastectomy module, the reconstruction module, the augmentation module and the reduction/mastopexy module, and to assess the psychometric properties of the mastectomy module among Japanese women...
March 2017: Breast Cancer: the Journal of the Japanese Breast Cancer Society
https://www.readbyqxmd.com/read/27146156/addition-of-vasopressin-synthetic-analogue-v-4-q-5-ddavp-to-standard-chemotherapy-enhances-tumour-growth-inhibition-and-impairs-metastatic-spread-in-aggressive-breast-tumour-models
#19
Juan Garona, Marina Pifano, Maria B Pastrian, Daniel E Gomez, Giselle V Ripoll, Daniel F Alonso
[V(4)Q(5)]dDAVP is a novel 2nd generation vasopressin analogue with robust antitumour activity against metastatic breast cancer. We recently reported that, by acting on vasopressin V2r membrane receptor present in tumour cells and microvascular endothelium, [V(4)Q(5)]dDAVP inhibits angiogenesis and metastatic progression of the disease without overt toxicity. Despite chemotherapy remaining as a primary therapeutic option for aggressive breast cancer, its use is limited by low selectivity and associated adverse effects...
August 2016: Clinical & Experimental Metastasis
https://www.readbyqxmd.com/read/27065661/patient-reported-outcomes-following-breast-reconstruction-surgery-and-therapeutic-mammoplasty-prospective-evaluation-1%C3%A2-year-post-surgery-with-breast-q-questionnaire
#20
Laxmi Shekhawat, Laleh Busheri, Santosh Dixit, Chaula Patel, Upendra Dhar, Chaitanyanand Koppiker
Breast Cancer (BC) treatment leads to mutilation and destruction of breast shape with negative effects on body image and self-esteem.One of the main goals of reconstructive and oncoplastic breast surgery is to satisfy patients and improve their quality of life (QoL).Therefore, it is important to assess the patient experience post-surgery by means of patient-reported outcome measures (PROMs) that focus on the patient's perception of the surgery and surgical care, as well as psychosocial well-being and physical functioning...
December 2015: Indian Journal of Surgical Oncology
keyword
keyword
26111
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"